• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR XACT CAROTID STENT SYSTEM; SELF EXPANDING PERIPHERAL STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR XACT CAROTID STENT SYSTEM; SELF EXPANDING PERIPHERAL STENT SYSTEM Back to Search Results
Model Number 82096-01
Device Problem Material Separation (1562)
Patient Problems Stroke/CVA (1770); Ischemia (1942); Thrombosis/Thrombus (4440)
Event Date 07/22/2021
Event Type  Injury  
Manufacturer Narrative
The device was not returned for evaluation.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other complaints reported from this lot.The reported patient effects of ischemia, thrombosis and stroke are listed in the xact instruction for use (ifu) as known adverse events potentially associated with carotid stents and embolic protection systems.Based on the information provided, a conclusive cause for the reported stent fracture and subsequent patient effects could not be determined.The unexpected medical intervention and hospitalization were related to circumstances of the procedure.There is no indication of a product quality issue with respect to the design, manufacture, or labeling of the device.The acculink stent referenced is filed under a separate medwatch report number.
 
Event Description
It was reported that on (b)(6) 2021, a 10tx40x136 xact carotid stent was implanted to treat an occlusion in the heavily calcified, mildly tortuous, 90% stenosed left vertebral artery.On (b)(6) 2021, the patient presented for a second planned procedure in another vessel; however, it was noted that the xact stent implanted in may was broken circumferentially and severely blocking the blood flow.A 7-10/40 acculink stent was implanted as treatment, relieving the patient symptoms.Post procedure, the patient experienced a cerebral infarction from thrombus and was hospitalized for observation.No additional information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XACT CAROTID STENT SYSTEM
Type of Device
SELF EXPANDING PERIPHERAL STENT SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 2024168
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key12305091
MDR Text Key266002024
Report Number2024168-2021-07065
Device Sequence Number1
Product Code NIM
UDI-Device Identifier08717648010323
UDI-Public08717648010323
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
P040038
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Reporter Occupation Physician
Type of Report Initial
Report Date 08/10/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/10/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/30/2023
Device Model Number82096-01
Device Catalogue Number82096-01
Device Lot Number0121561
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received07/23/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/15/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention; Disability;
-
-